Confirmation of the donor origin of de novo hepatocellular carcinoma after liver transplant using microsatellite analysis

被引:0
作者
Zhang, Wei [1 ]
Houldsworth, Jane [2 ]
Schiano, Thomas D. [3 ]
Fiel, M. Isabel [2 ]
机构
[1] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA
[2] Mt Sinai Med Ctr, Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA
[3] Mt Sinai Med Ctr, Recanati Miller Transplantat Inst, New York, NY USA
关键词
de novo; hepatocellular carcinoma; liver transplant; obliterative portal venopathy; nodular regenerative hyperplasia; RECURRENCE; MALIGNANCY; ALLOGRAFT; RECIPIENT;
D O I
10.1093/ajcp/aqaf078
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective The recurrence of hepatocellular carcinoma (HCC) after liver transplant (LT) occurs in 10% to 15% of cases, but de novo HCC arising in an allograft is a rare occurrence. The aim of this study was to determine the origin of post-LT de novo HCC as either donor or recipient by using molecular analysis.Methods Using the LT database (2000-2019), a search was performed for patients who developed de novo HCC and underwent a second LT. Archival formalin-fixed, paraffin-embedded blocks were retrieved. Fragment analysis of 16 polymorphic short tandem repeat (STR) loci was performed on the de novo tumor, background allograft liver, and a recipient control tissue. The origin of the de novo HCC was determined by comparing the informative STR-polymerase chain reaction products from the 3 different specimen sources.Results Histologically, the HCC showed well to moderately differentiated morphology. Obliterative portal venopathy (OPV) was seen in all 4 cases, and 2 cases showed nodular regenerative hyperplasia (NRH); cirrhosis was absent in all cases. All HCCs were of donor origin.Conclusions Our study shows that in this cohort, all de novo HCCs were of donor origin, and OPV/NRH was a common concurrent finding. Short tandem repeat analysis is helpful in differentiating whether HCC in the appropriate post-LT clinical setting is of donor origin.
引用
收藏
页数:8
相关论文
共 20 条
[1]   Obliterative Portal Venopathy: A Clinical and Histopathological Review [J].
Aggarwal, Sourabh ;
Fiel, M. Isabel ;
Schiano, Thomas D. .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (10) :2767-2776
[2]   Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement [J].
Al-Adra, David P. ;
Hammel, Laura ;
Roberts, John ;
Woodle, E. Steve ;
Levine, Deborah ;
Mandelbrot, Didier ;
Verna, Elizabeth ;
Locke, Jayme ;
D'Cunha, Jonathan ;
Farr, Maryjane ;
Sawinski, Deirdre ;
Agarwal, Piyush K. ;
Plichta, Jennifer ;
Pruthi, Sandhya ;
Farr, Deborah ;
Carvajal, Richard ;
Walker, John ;
Zwald, Fiona ;
Habermann, Thomas ;
Gertz, Morie ;
Bierman, Philip ;
Dizon, Don S. ;
Langstraat, Carrie ;
Al-Qaoud, Talal ;
Eggener, Scott ;
Richgels, John P. ;
Chang, George J. ;
Geltzeiler, Cristina ;
Sapisochin, Gonzalo ;
Ricciardi, Rocco ;
Krupnick, Alexander S. ;
Kennedy, Cassie ;
Mohindra, Nisha ;
Foley, David P. ;
Watt, Kymberly D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (02) :460-474
[3]   Nodular Regenerative Hyperplasia After Liver Transplant; It's All in the Presentation [J].
Chen, Allen K. ;
Lunow-Luke, Tyler ;
Yamaguchi, Seiji ;
Praglin, Claudia ;
Agudelo, Eliana ;
Mehta, Neil ;
Dirks, Rachel ;
Braun, Hillary J. ;
Gardner, James M. ;
Roberts, John P. ;
Syed, Shareef M. ;
Roll, Garrett R. .
FRONTIERS IN SURGERY, 2022, 9
[4]   De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference [J].
Colmenero, Jordi ;
Tabrizian, Parissa ;
Bhangui, Prashant ;
Pinato, David James ;
Rodriguez-Peralvarez, Manuel L. ;
Sapisochin, Gonzalo ;
Bhoori, Sherrie ;
Pascual, Sonia ;
Senzolo, Marco ;
Al-Adra, David ;
Herrero, J. Ignacio ;
Petrowsky, Henrik ;
Dawson, Laura A. ;
Hosni, Ali ;
Kutzke, Jade L. ;
Gastaca, Mikel ;
Watt, Kymberly D. .
TRANSPLANTATION, 2022, 106 (01) :E30-E45
[5]   Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation [J].
Devarbhavi, Harshad ;
Abraharn, Susan ;
Kamath, Patrick S. .
LIVER TRANSPLANTATION, 2007, 13 (11) :1552-1556
[6]   Hepatocellular carcinoma in obliterative portal venopathy [J].
El Homsi, Maria ;
Fiel, M. Isabel ;
Taouli, Bachir .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2021, 102 (02) :115-116
[7]   De novo hepatocellular carcinoma in a non-cirrhotic allograft 27 years after liver transplantation: A case report [J].
El-domiaty, Nada ;
Saliba, Faouzi ;
Sebagh, Mylene ;
Salloum, Chady ;
Vibert, Eric ;
Azoulay, Daniel ;
Hamelin, Jocelyne ;
Cherqui, Daniel ;
Adam, Rene ;
Samuel, Didier .
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (05) :1953-1958
[8]   Donor-Transmitted Malignancy in a Liver Transplant Recipient: A Case Report and Review of Literature [J].
Kim, Brian ;
Woreta, Tinsay ;
Chen, Po-Hung ;
Limketkai, Berkeley ;
Singer, Andrew ;
Dagher, Nabil ;
Cameron, Andrew ;
Lin, Ming-Tseh ;
Kamel, Ihab ;
Gurakar, Ahmet .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (05) :1185-1190
[9]   Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation [J].
Kim, Minjeong ;
Rhu, Jinsoo ;
Choi, Gyu-Seong ;
Kim, Jong Man ;
Joh, Jae-Won .
ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 101 (01) :28-36
[10]   Recurrent Liver Allograft Injury in Patients With Donor-Derived Malignancy Treated With Immunosuppression Cessation and Retransplantation [J].
Lee, Brian T. ;
Ganjoo, Naveen ;
Fiel, M. Isabel ;
Hechtman, Jackie F. ;
Sarkar, Suparna A. ;
Kim-Schluger, Leona ;
Florman, Sander S. ;
Schiano, Thomas D. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (02) :199-205